Table 2.
Laboratory findings (normal range) | Ranges in our study | Number of patients (percentage) | Median value (25th-75th percentile) |
---|---|---|---|
Total leukocyte count (TLC) (4-10×109/L) | <4 | 0 | 14.3 (10.3-18.14) |
4-10 | 30 (23.26%) | ||
>10 | 99 (76.74%) | ||
Neutrophil lymphocyte ratio (NLR) | ≤ 5 | 12 (9.3%) | 1.6 (8-19.8) |
>5 | 117 (90.7%) | ||
Haemoglobin (12-17.5 g/L) | <8 | 2 (2.52%) | 12.6 (11.21-14.09) |
8-12 | 23 (23.53%) | ||
>12 | 89 (73.95%) | ||
Platelets (150-400×109/L) | <100 | 23 (18.85%) | 160 (111.25-235.75) |
100-149 | 29 (23.77%) | ||
>=150 | 70 (57.38%) | ||
Creatinine (0.7-1.3 mg/dL) | <1.3 | 80 (62.50%) | 1.27 (1.05-1.785) |
≥1.3 | 48 (37.50%) | ||
Aspartate transaminase (AST) (<45 U/L) | ≤45 | 44 (33.59%) | 66 (36-121) |
>45 to 100 | 48 (36.64%) | ||
>100 | 39 (29.77%) | ||
Alanine transaminase (ALT) (<45 U/L) | ≤45 | 52 (40.00%) | 57.5 (35.125-104.75) |
>45-100 | 42 (32.31%) | ||
>100 | 36 (27.69%) | ||
Albumin (35-52 g/L) | <35 | 50 (37.88%) | 3.6 (3.45-3.86) |
>35 | 82 (62.12%) | ||
C reactive protein (CRP) (<1 mg/L) | <10 | 02 (1.96%) | 101.85 (69.825-129.325) |
10 to<50 | 11 (10.78%) | ||
50 to<100 | 35 (34.31%) | ||
≥100 | 54 (52.94%) | ||
Lactate dehydrogenase (LDH) (140-280 U/L) | <280 | 3 (2.24%) | 879.95 (666.2-1163.875) |
≥280 | 131 (97.76%) | ||
D dimer (<0.5 µgm/mL) | <0.5 | 13 (9.70%) | 0.93 (0.655-2.035) |
0.5 to 1 | 57 (42.54%) | ||
>1 | 64 (47.76%) | ||
Ferritin (20-300 µgm/L) | <300 | 5 (3.73%) | 873.95 (650.225-1332.25) |
≥300 | 129 (96.27%) | ||
Interleukin-6 (IL-6) (<7 pg/mL) | ≥7 | 57 (100%) | 190.44 (76-312) |
Procalcitonin (<0.1 ng/mL) | <0.5 | 5 (19.23%) | 2.05 (0.8-4.45) |
0.5 to 1 | 2 (7.69%) | ||
>1 | 19 (73.08%) |